Advisor Group Holdings, Inc. Galera Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.17 - $3.0 $340 - $6,000	2,000 Added 133.33%	3,500 $0
Q2 2023 Aug 10, 2023	BUY	$2.5 - $3.42 $3,750 - $5,130	1,500 New	1,500 $4,000
Q1 2022 May 04, 2022	SELL	$2.01 - $4.19 $2,221 - $4,629	-1,105 Reduced 91.17%	107 $0
Q3 2021 Nov 05, 2021	SELL	$7.04 - $10.49 $5,568 - $8,297	-791 Reduced 39.49%	1,212 $10,000
Q2 2021 Aug 02, 2021	BUY	$6.08 - $10.44 $9,059 - $15,555	1,490 Added 290.45%	2,003 $20,000

Q1 2021 May 13, 2021	BUY	$8.35 - $12.39 $4,283 - $6,356	513 New	513 $5,000

10.7M

10.3K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $3.76M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.